Skip to main content
Clinical Trials/NCT06826274
NCT06826274Not yet recruitingNot Applicable

Clinical and Neurophysiological Evaluation of the Effects of Cervical TsDCS on Stroke Patients with Distal Upper Limb Strength Deficit

IRCCS San Raffaele Roma1 site in 1 country40 target enrollmentStarted: March 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
improvement of paretic hand performance

Study Overview

Brief Summary

The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Group Stroke:
  • •Inclusion criteria:
  • •age over 18 years;
  • •first ischemic/hemorrhagic stroke (within 30 days of onset);
  • •mild-to-moderate stroke (NIHSS scale score<16).
  • •residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3;
  • •ability to give informed consent and understand instructions.

Exclusion Criteria

  • •severe spasticity (Ashworth Scale score > 2);
  • •severe aphasia;
  • •severe neglect;
  • •history of disabling neurological disease;
  • •history of epilepsy;
  • •significant comorbidities;
  • •contraindications to tsDCS.
  • •Healthy Group:
  • •Inclusion criteria:
  • •age over 18 years;
  • •equalized in age with the patient group.
  • •Exclusion criteria:
  • •history of stroke progress;
  • •history of severe neurological disease.

Arms & Interventions

Healthy

Experimental

Intervention: tDCS (Other)

Stroke

Experimental

Intervention: tDCS (Other)

Outcomes

Primary Outcomes

improvement of paretic hand performance

Time Frame: through study completion, an average of 1 year

The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Reaching

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
IRCCS San Raffaele Roma
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials